Biotech venture champion Bill Maris is exiting GV. What’s next?
In the biotech startup world, GV (the venture group still usually referred to by its original name, Google Ventures) is the ideal investor. They bring legendary connections, seemingly endless cash resources and the kind of tech endorsement that can leave you smiling in your sleep. And now the champion of life sciences investing at GV, Bill Maris, is stepping away from the helm after founding it 8 years ago.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.